Literature DB >> 2428481

Enhancement of O6-methylguanine-DNA-methyltransferase activity induced by various treatments in mammalian cells.

P Lefebvre, F Laval.   

Abstract

The O6-methylguanine-DNA-methyltransferase (methyltransferase) activity was determined in a rat hepatoma cell line after treatment with ultraviolet or gamma-irradiation, heat treatment, or incubation with cis-diamminedichloroplatinum(II),2-methyl-9-hydroxyellipticinium, or bleomycin. The assay measured the removal of O6-methylguanine from 3H-alkylated DNA by cellular extracts. The results show that 48 h after the various treatments, the methyltransferase activity is increased by 2- to 5-fold. This increase is due to de novo specific protein synthesis. It is not related to a modification of the cell cycle parameters, as a similar enhancement is observed in plateau-phase cells treated with ionizing radiations or cis-dichlorodiammineplatinum(II). The increase of the methyltransferase activity measured using an alkylated substrate represents an actual increase of the active molecules in the cells, as the mutation frequency is much lower in cells treated with N-methyl-N'-nitro-N-nitrosoguanidine 48 h after an irradiation (3 Gy) than in nonirradiated cells. This induction of the methyltransferase was not observed in Chinese hamster ovary cells after gamma-irradiation, and therefore it does not seem to occur in cells which have a low constitutive level of O6-methylguanine repair.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2428481

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  After X-irradiation a transient arrest of L929 cells in G2-phase coincides with a rapid elevation of the level of O6-alkylguanine-DNA alkyltransferase.

Authors:  P Nehls; D van Beuningen; M Karwowski
Journal:  Radiat Environ Biophys       Date:  1991       Impact factor: 1.925

Review 2.  Self-destruction and tolerance in resistance of mammalian cells to alkylation damage.

Authors:  P Karran; M Bignami
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

3.  O6-Alkylguanine-DNA alkyltransferase content in synchronised human cancer cells.

Authors:  P Coccia; S Sen; E Erba; P Pagani; C Marinello; M D'Incalci
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Evidence that covalent complex formation between BCNU-treated oligonucleotides and E. coli alkyltransferases requires the O6-alkylguanine function.

Authors:  P E Gonzaga; L Harris; G P Margison; T P Brent
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

5.  Repair of O-alkylpyrimidines in mammalian cells: a present consensus.

Authors:  T P Brent; M E Dolan; H Fraenkel-Conrat; J Hall; P Karran; L Laval; G P Margison; R Montesano; A E Pegg; P M Potter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

6.  Mutagenesis by O6 meG residues within codon 12 of the human Ha-ras proto-oncogene in monkey cells.

Authors:  V Pletsa; A Gentil; A Margot; J Armier; S A Kyrtopoulos; A Sarasin
Journal:  Nucleic Acids Res       Date:  1992-09-25       Impact factor: 16.971

7.  Inducibility of the DNA repair gene encoding O6-methylguanine-DNA methyltransferase in mammalian cells by DNA-damaging treatments.

Authors:  G Fritz; K Tano; S Mitra; B Kaina
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

8.  A constitutive damage-specific DNA-binding protein is synthesized at higher levels in UV-irradiated primate cells.

Authors:  S Hirschfeld; A S Levine; K Ozato; M Protić
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

9.  Isolation and structure of a cDNA expressing a mammalian 3-methyladenine-DNA glycosylase.

Authors:  T R O'Connor; F Laval
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

10.  O6-alkylguanine-DNA-alkyltransferase activity and nitrosourea sensitivity in human cancer cell lines.

Authors:  M C Walker; J R Masters; G P Margison
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.